Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Duplex vertical flow rapid tests for point-of-care detection of anti-dsDNA and anti-nuclear autoantibodies

Version 1 : Received: 16 January 2024 / Approved: 18 January 2024 / Online: 19 January 2024 (09:22:54 CET)

A peer-reviewed article of this Preprint also exists.

Lei, R.; Arain, H.; Wang, D.; Arunachalam, J.; Saxena, R.; Mohan, C. Duplex Vertical-Flow Rapid Tests for Point-of-Care Detection of Anti-dsDNA and Anti-Nuclear Autoantibodies. Biosensors 2024, 14, 98. Lei, R.; Arain, H.; Wang, D.; Arunachalam, J.; Saxena, R.; Mohan, C. Duplex Vertical-Flow Rapid Tests for Point-of-Care Detection of Anti-dsDNA and Anti-Nuclear Autoantibodies. Biosensors 2024, 14, 98.

Abstract

The goal of this study was to develop a rapid diagnostic kit for rheumatic disease and systemic lupus erythematosus (SLE) screening. A novel rapid vertical flow assay (VFA) was engineered and used to assay anti-nuclear (ANA) and anti-dsDNA (αDNA) autoantibodies from systemic lupus erythematosus (SLE) patients and healthy controls (HC). Observer scores and absolute signal intensities from the VFA were validated by ELISA. The rapid ten minute point of care VFA test engineered demonstrated a limit of detection of 0.5 IU/ml for ANA and αDNA autoantibodies in human plasma with inter-operator CV of 19% for ANA and 12% for αDNA. Storage stability was verified over a three-month period. When testing anti-dsDNA and ANA levels in 22 SLE and 18 HC serum samples, the duplex VFA revealed 95% sensitivity, 72% specificity and 84% accuracy in discriminating disease groups, comparable to the gold standard, ELISA. The rapid αDNA/ANA duplex VFA can potentially be used in primary care clinics for evaluating patients or at-risk subjects for rheumatic diseases and for planning follow-up testing. Given its low cost, ease and rapid turnaround, it can also be used to assess SLE prevalence estimates.

Keywords

anti-nuclear antibody, anti-dsDNA antibody, vertical flow assay, Gold nanoparticles, rheumatic disease

Subject

Chemistry and Materials Science, Applied Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.